GlassScriptPhysician profile
Matthew John Herring
NPI 1609219658
$100,005.94
in general payments reported to CMS, 2019-2025
13 companies · $28K in 2025
The $28K reported for 2025 was more than what 88% of Orthopaedic Trauma providers received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,820 · 2020: $5,626 · 2021: $13K · 2022: $5,512 · 2023: $19K · 2024: $27K · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $69K · Travel and Lodging: $2,991 · Food and Beverage: $1,808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $68,780.49 |
| Travel and Lodging | $2,990.93 |
| Food and Beverage | $1,808.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trilliant Surgical LLC. | $92,159.73 | 2020-2025 | Arsenal Ankle 10 Hole 1/3 Tubular Plate |
| Stryker Corporation | $4,841.36 | 2019-2025 | Pro, Pangea, Gamma |
| Synthes Gmbh | $1,058.24 | 2019 | |
| Depuy Synthes Sales INC. | $682.83 | 2019-2025 | Na, Va-Lcp, Fibergraft Bg Morsels |
| Medshape, INC. | $467.74 | 2021 | |
| Smith+Nephew, INC. | $288.69 | 2019-2022 | |
| Skeletal Dynamics INC | $172.87 | 2019 | |
| Arthrex, INC. | $125.66 | 2025 | |
| Encore Medical, LP | $96.89 | 2021 | |
| Baxter Healthcare | $36.41 | 2022 | |
| Bioventus LLC | $31.36 | 2020 | |
| Pacira Therapeutics, INC. | $24.76 | 2020 | |
| Amgen INC. | $19.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Herring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.